WEKO3
-
RootNode
アイテム
The study of serum Superoxide Dismutase activity in children with renal diseases
http://hdl.handle.net/10191/33597
http://hdl.handle.net/10191/3359781698310-0659-44c1-a8b7-06a75296da03
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
34(2)_55-64.pdf (1.0 MB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2015-10-08 | |||||
| タイトル | ||||||
| タイトル | The study of serum Superoxide Dismutase activity in children with renal diseases | |||||
| タイトル | ||||||
| タイトル | The study of serum Superoxide Dismutase activity in children with renal diseases | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源 | http://purl.org/coar/resource_type/c_6501 | |||||
| タイプ | departmental bulletin paper | |||||
| 著者 |
Hirano, Harunobu
× Hirano, Harunobu |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Superoxide dismutase (SOD) is known to be a specific enzyme that scavenges superoxide and protects from tissue injury. The author investigated serum SOD activity in children with renal diseases. Serum SOD activity in MPGN was low (6.7 ±4.9 μg/ml, P < 0.01), as it also in PSAGN at the acute phase (8.0 ± 5.7 μg/ml, P <0.05), in comparison with the controls. In the cases of CGN, the more serious the histological diagnosis was, the lower the tendency of serum SOD activity showed. Low SOD activity is considered to be closely associated with the active phase of renal disease. Superoxide can be a vital activator in glomerular injury. SOD can be a healing factor in renal disease. | |||||
| 書誌情報 |
Acta medica et biologica en : Acta medica et biologica 巻 34, 号 2, p. 55-64, 発行日 1986-09 |
|||||
| 出版者 | ||||||
| 出版者 | Niigata University School of Medicine | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 05677734 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00508361 | |||||
| 著者版フラグ | ||||||
| 値 | publisher | |||||
Share
Cite as
Hirano, Harunobu, 1986, The study of serum Superoxide Dismutase activity in children with renal diseases: Niigata University School of Medicine, 55–64 p.
Loading...
